A seasoned drug development manager specializing in preclinical strategy and IND-enabling programs for ophthalmology. A proven leader, he excels in advancing novel therapeutics from concept to clinic through expert study design, CRO management, and regulatory alignment. Dr. Jamison has a distinguished track record of entrepreneurship, having co-founded ONL Therapeutics and founded multiple successful ventures, including a specialized ocular CRO and a medical device company. His career includes senior scientific roles at Alcon and Pfizer, and he is highly skilled in securing funding, building cross-functional teams, and driving innovation in ocular disease modeling and vision assessment techniques.